Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1989 2
1990 4
1991 4
1992 6
1993 8
1994 3
1995 4
1996 1
1997 5
1998 7
1999 7
2000 7
2001 4
2002 13
2003 8
2004 3
2005 9
2006 5
2007 1
2008 6
2009 6
2010 2
2011 5
2012 2
2013 2
2014 4
2015 2
2016 2
2017 1
2018 1
2020 1
2021 8
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJ, Robert L, Chmielowski B, Spasic M, Henry G, Ciobanu V, West AN, Carmona M, Kivork C, Seja E, Cherry G, Gutierrez AJ, Grogan TR, Mateus C, Tomasic G, Glaspy JA, Emerson RO, Robins H, Pierce RH, Elashoff DA, Robert C, Ribas A. Tumeh PC, et al. Among authors: glaspy ja. Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954. Nature. 2014. PMID: 25428505 Free PMC article. Clinical Trial.
Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy.
Wainberg ZA, Singh AS, Konecny GE, McCann KE, Hecht JR, Goldman J, Chmielowski B, Finn RS, O'Brien N, Von Euw E, Price MM, Martinez D, Yonemoto L, Brennan M, Glaspy JA, Slamon DJ. Wainberg ZA, et al. Among authors: glaspy ja. Clin Cancer Res. 2023 Jan 4;29(1):40-49. doi: 10.1158/1078-0432.CCR-22-1553. Clin Cancer Res. 2023. PMID: 36136304 Clinical Trial.
A careful reassessment of anthracycline use in curable breast cancer.
Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, Fasching PA, Ejlertsen B, Yang EH, Glaspy JA, Slamon DJ. Hurvitz SA, et al. Among authors: glaspy ja. NPJ Breast Cancer. 2021 Oct 8;7(1):134. doi: 10.1038/s41523-021-00342-5. NPJ Breast Cancer. 2021. PMID: 34625570 Free PMC article. Review.
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.
Nguyen VP, Campbell KM, Nowicki TS, Elumalai N, Medina E, Baselga-Carretero I, DiNome ML, Chang HR, Oseguera DK, Ribas A, Glaspy JA. Nguyen VP, et al. Among authors: glaspy ja. Cancer Res Commun. 2023 Aug 23;3(8):1628-1637. doi: 10.1158/2767-9764.CRC-23-0145. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37621406 Free PMC article. Clinical Trial.
Risks for Anaphylaxis With Intravenous Iron Formulations.
Al-Samkari H, Glaspy JA, Means RT Jr, Chertow GM, Auerbach M. Al-Samkari H, et al. Among authors: glaspy ja. Ann Intern Med. 2022 Nov;175(11):W143. doi: 10.7326/L22-0282. Ann Intern Med. 2022. PMID: 36375165 No abstract available.
Cancer immunotherapy using gene-modified dendritic cells.
Ribas A, Butterfield LH, Glaspy JA, Economou JS. Ribas A, et al. Among authors: glaspy ja. Curr Gene Ther. 2002 Feb;2(1):57-78. doi: 10.2174/1566523023348129. Curr Gene Ther. 2002. PMID: 12108974 Review.
Financial Toxicity From Generic Specialty Drug Use.
Fischer KA, Miller RE, Glaspy JA. Fischer KA, et al. Among authors: glaspy ja. JAMA Oncol. 2021 Feb 1;7(2):175-176. doi: 10.1001/jamaoncol.2020.5181. JAMA Oncol. 2021. PMID: 33211083 No abstract available.
Erythropoietin in cancer patients.
Glaspy JA. Glaspy JA. Annu Rev Med. 2009;60:181-92. doi: 10.1146/annurev.med.60.050307.110718. Annu Rev Med. 2009. PMID: 18980468 Review.
149 results